Level Four Advisory Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.09M Buy
33,434
+746
+2% +$146K 0.2% 133
2026
Q1
$6.41M Sell
32,688
-2,174
-6% -$422K 0.21% 133
2025
Q4
$6.05M Buy
34,862
+127
+0.4% +$23.1K 0.2% 137
2025
Q3
$6.62M Buy
34,735
+627
+2% +$111K 0.23% 114
2025
Q2
$6.13M Buy
34,108
+153
+0.5% +$26.6K 0.23% 124
2025
Q1
$5.75M Sell
33,955
-2,156
-6% -$354K 0.24% 125
2024
Q4
$5.45M Buy
36,111
+670
+2% +$104K 0.22% 121
2024
Q3
$5.49M Buy
35,441
+3,183
+10% +$475K 0.23% 126
2024
Q2
$4.42M Buy
+32,258
New +$4.42M 0.2% 145
2019
Q1
Sell
-2,978
Closed -$248K 519
2018
Q4
$248K Sell
2,978
-1,793
-38% -$168K 0.03% 436
2018
Q3
$515K Buy
4,771
+352
+8% +$38.6K 0.06% 335
2018
Q2
$486K Buy
+4,419
New +$460K 0.04% 391

Other funds holding DGX

Level Four Advisory Services's DGX Position: Q2 2026 in Review

Level Four Advisory Services increased its Quest Diagnostics (DGX) stake by 2.3% in Q2 2026, buying an estimated $146K and bringing the position to 33,434 shares worth $7.09M. The position accounts for 0.2% of the portfolio, ranked #133.

Level Four Advisory Services first reported a position in DGX in Q2 2018 and has held it in 12 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Level Four Advisory Services held 33,434 shares of Quest Diagnostics worth $7.09M as of Q2 2026.
  • Level Four Advisory Services bought 746 Quest Diagnostics shares in Q2 2026, an estimated $146K.
  • Quest Diagnostics made up 0.2% of Level Four Advisory Services's portfolio in Q2 2026, its #133 holding.
  • Level Four Advisory Services first reported a position in Quest Diagnostics in Q2 2018 and has held it in 12 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.